Goldman Steven Harold 4
4 · STELLAR PHARMACEUTICALS INC · Filed Sep 6, 2012
Insider Transaction Report
Form 4
Goldman Steven Harold
Director
Transactions
- Purchase
Common Share
2012-09-04$0.50/sh+20,500$10,250→ 1,020,646 total(indirect: Lambent Consulting Corp) - Purchase
Common Shares
2012-09-05$0.51/sh+10,000$5,050→ 1,105,146 total(indirect: Lambent Consulting Corp) - Purchase
Common Shares
2012-09-05$0.50/sh+44,500$22,250→ 1,065,146 total(indirect: Lambent Consulting Corp) - Purchase
Common Shares
2012-09-05$0.49/sh+30,000$14,700→ 1,095,146 total(indirect: Lambent Consulting Corp)